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Hyaluronan Metabolism in Human Keratinocytes
and Atopic Dermatitis Skin Is Driven by a Balance
of Hyaluronan Synthases 1 and 3
Je´re´my Malaisse1, Virginie Bourguignon1, Evelyne De Vuyst1, Catherine Lambert de Rouvroit1,
Arjen F. Nikkels2, Bruno Flamion1 and Yves Poumay1
Hyaluronan (HA) is a glycosaminoglycan synthesized directly into the extracellular matrix by three hyaluronan
synthases (HAS1, HAS2, and HAS3). HA is abundantly synthesized by keratinocytes but its epidermal functions
remain unclear. We used culture models to grow human keratinocytes as autocrine monolayers or as
reconstructed human epidermis (RHE) to assess HA synthesis and HAS expression levels during the course of
keratinocyte differentiation. In both the models, epidermal differentiation downregulates HAS3 mRNA expres-
sion while increasing HAS1 without significant changes in hyaluronidase expression. HA production correlates
with HAS1 mRNA expression level during normal differentiation. To investigate the regulation of HAS gene
expression during inflammatory conditions linked to perturbed differentiation, lesional and non-lesional skin
biopsies of atopic dermatitis (AD) patients were analyzed. HAS3 mRNA expression level increases in AD lesions
compared with healthy and non-lesional skin. Simultaneously, HAS1 expression decreases. Heparin-binding EGF-
like growth factor (HB-EGF) is upregulated in AD epidermis. An AD-like HAS expression pattern is observed in
RHE incubated with HB-EGF. These results indicate that HAS1 is the main enzyme responsible for HA production
by normal keratinocytes and thus, must be considered as an actor of normal keratinocyte differentiation. In
contrast, HAS3 can be induced by HB-EGF and seems mainly involved in AD epidermis.
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INTRODUCTION
Hyaluronan (HA) is an essential extracellular polysaccharide.
Its abundance in dermis and epidermis contrasts with the lack
of understanding of its functions in skin. HA is composed of
alternating glucuronic acid and N-acetylglucosamine residues
repeated several thousands of times to form a linear non-
sulfated glycosaminoglycan (Toole, 2004). HA is produced
at the inner cell membrane and directly exported to the
extracellular space by three enzymes called hyaluronan
synthases (HASs) 1, 2, and 3 (Rilla et al., 2005). The three
HASs differ by their temporal expression during development,
their specific activity, and the size of the respective HA
polymers they produce (Itano et al., 1999). HAS2 appears to
have a key role during development, as deletion of its gene in
mice is lethal at mid-gestation, due to multiple cardiovascular
malformations (Camenisch et al., 2000). On the other hand,
HAS1 and HAS3 null mice are viable (Bai et al., 2005;
Kobayashi et al., 2010) as well as double-knockout mice
lacking HAS1 and HAS3 (Mack et al., 2011). Enzymatic
catabolism of HA is performed by hyaluronidases,
mainly HYAL1 and HYAL2 (Toole, 2004). The skin contains
50% of the total body HA (Meyer and Stern, 1994).
Labeling using a biotinylated HA-binding protein shows that
HA is abundant in the dermis and to a lesser extent in the
epidermis. In the latter, HA is mainly localized around the
cells of basal and spinous layers (Tuhkanen et al., 1998).
Involvement of HA and HASs in proliferation, differentiation,
and migration of keratinocytes, as well as in the establishment
of the epidermal barrier, has been reported (Maytin et al.,
2004; Passi et al., 2004; Rilla et al., 2004; Bourguignon et al.,
2006; Farwick et al., 2011). Yet, the mechanisms of HA
involvement in normal epidermis are not well identified or
understood.
Increased HA synthesis has been implicated in skin inflam-
mation. An increase in HA staining parallel to an increase in
HAS3 mRNA expression is observed in acute eczema (Ohtani
et al., 2009). HAS2 and HAS3 in keratinocytes can be
upregulated by pro-inflammatory cytokines such as IL4,
IL13, and IFN-g (Sayo et al., 2002), by growth factors such
as EGF or keratinocyte growth factor (Karvinen et al., 2003;
Pasonen-Seppanen et al., 2003), or by retinoic acid (RA)
(Saavalainen et al., 2005; Pasonen-Seppanen et al., 2008).
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However, the specific regulation of HAS genes during
spontaneous proliferation and differentiation of keratinocytes
or during the establishment of the epidermal barrier has not
yet been characterized.
Here, we have investigated HA synthesis in normal human
keratinocytes using two culture models of epidermal differ-
entiation induced by cell density, i.e., confluent keratinocyte
monolayers and reconstructed human epidermis (RHE), both
cultured without addition of molecules influencing the differ-
entiation processes (Minner et al., 2010; Frankart et al., 2012),
as well as in lesional and non-lesional skin from atopic
dermatitis (AD) patients. Our data strikingly suggest that the
balance of HA produced by distinct HASs is differentially
involved in the regulation of keratinocyte physiology and
pathophysiology: HAS1 is responsible for the bulk of HA
production in normal keratinocytes, whereas HAS3 is
prominent in pathological conditions. These observations
pave the way to targeted HA modulation therapies.
RESULTS
Production of HA by human keratinocytes correlates with
expression levels of HAS1 during differentiation and
dedifferentiation
Autocrine cultures of human keratinocytes undergo differen-
tiation as cells become confluent (Minner et al., 2010). HA
concentration was measured in the culture medium, the peri-
cellular zone, and the intracellular compartment of human
keratinocyte monolayers before and after confluence. HA
accumulates in the medium and around the cells mainly
after culture confluence (Figure 1a and b). The amount of
intracellular HA (Figure 1c) is variable, whereas extracellular
HA increases progressively and markedly with differentiation
(Figure 1a, b and e). One may surmise that pericellular HA
continuously diffuses into the culture medium. This pattern of
HA production suggests an active role concomitant with
differentiation of keratinocytes. Because HA’s functions are
size-dependent, we analyzed the molecular weight of newly
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Figure 1. Hyaluronan (HA) concentration and hyaluronan synthases (HASs) expression correlate with epidermal differentiation in keratinocyte monolayers.
HA amounts (means±SEM of triplicates) in culture medium (a), released by trypsin incubation (pericellular HA; b), or measured in total cell extracts (intracellular
HA; c) of keratinocyte autocrine monolayers were determined every 48 hours, starting two days before confluence (C 2 days) until four days after confluence
(Cþ 4 days) and normalized to cell proteins. The expression of the three main HASs was measured by real-time PCR during the growth of autocrine monolayers
(d) or in confluent cultures incubated for 18 hours with all-trans retinoic acid (RA) (10 9–106 mol l 1) or DMSO as control (f). Epidermal differentiation was
analyzed by measuring the relative expression levels of keratin 10 (KRT10) and involucrin (IVL) mRNA (e, g). The mRNA levels at C 2 days (e) and DMSO
(g) were arbitrarily fixed at 1. The y axis is a logarithmic scale and error bars represent 95% confidence intervals (n¼ 3, analysis of variance one-repetition
maximum, *Po0.05, **Po0.01, ***Po0.001 vs. C 2 days or DMSO).
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synthesized HA released into the medium at different culture
steps (Supplementary Figure S1a online). Various sizes of HA
were detected in each condition with a peak around B2,000
kDa. There were no significant changes in HA molecular size
during differentiation.
To determine if one particular HAS is specifically involved
in the enhanced production of HA by differentiating keratino-
cytes, the mRNA expression levels of HAS1, HAS2, and HAS3
were determined by quantitative PCR. The relative expression
level of HAS1 mRNA increases 5-fold at confluence and
between 5- and 10-fold after confluence (Figure 1d). In
contrast, the relative expression levels of HAS2 and HAS3
mRNA decrease significantly as soon as cultures become
confluent and express differentiation markers (Figure 1e). We
also measured the mRNA expression of HYAL1 and HYAL2
during the same time frame (Supplementary Figure S2a and b
online). Both are stable, suggesting that upregulation of HAS1
is the main driver of HA accumulation during differentiation.
To probe the potential link between keratinocyte differen-
tiation and expressions of specific HASs, confluent cultures
were incubated for 18 hours with various concentrations
of all-trans RA, a well-known inducer of epidermal
dedifferentiation (Poumay et al., 1999; Giltaire et al., 2009).
This treatment strongly downregulates keratin 10 (KRT10) and
upregulates involucrin (IVL) (Figure 1g). Simultaneously, the
mRNA levels of HAS2 and HAS3 dose-dependently increase,
wheread those of HAS1 decrease 410-fold. The effect of RA
on HAS2 and HAS3 expressions has been previously
described (Kaya et al., 2005; Saavalainen et al., 2005); our
experiments highlight downregulation of HAS1 expression
concomitantly with KRT10 disappearance (Figure 1f).
The role of the EGFR in the correlation between HAS
expression and keratinocyte differentiation was then evalu-
ated. EGFR, especially when phosphorylated EGFR, is known
to regulate the expression of numerous genes involved in diffe-
rentiation (Tran et al., 2012). The abundance of EGFR and
phosphorylated EGFR was assessed on western blots before
and after confluence of keratinocyte cultures. Both forms of
EGFR are detected at progressively lower levels as keratino-
cytes differentiate and express higher amounts of KRT10
(Supplementary Figure S3a online). To test whether EGFR also
controls the balance of HAS expression, subconfluent (C 2
days) keratinocytes were treated with the EGFR-neutralizing
antibody LA1 for 48 hours. LA1 blocks EGFR phosphorylation
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Figure 2. Analysis of hyaluronan (HA) depletion by 4-methylumbelliferone (4MU) or Streptomyces hyaluronidase (Hase) on relative mRNA expression
levels of involucrin (IVL), filaggrin (FLG), and keratin 10 (KRT10) in monolayer culture of keratinocytes during their epidermal differentiation. Keratinocytes
were grown in monolayer and the differentiation was induced by confluence. Cells were treated with 1 U ml1 of Hase (a, c, e) or 0.5 mM of 4MU (b, d, f) during
48 hours at each confluence stages. The expression of KRT10 (a, b), IVL (c, d), and FLG (e, f) was measured by real-time PCR and expression levels were
normalized to the average expression of two housekeeping genes (RPLP0 and TBP). The mRNA levels in control conditions were taken as references and arbitrarily
fixed at 1. The y axis is a logarithmic scale and error bars represent 95% confidence intervals (n¼ 3, analysis of variance two-repetition maximum).
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(Supplementary Figure S3b online) while increasing HAS1
expression 10-fold and decreasing HAS3 expression 10-fold
(Supplementary Figure S3c online).
In summary, the HAS1/HAS3 expression ratio robustly
correlates with keratinocyte differentiation state during both
spontaneous differentiation and pharmacological treatments;
EGFR may be involved in that switch.
Depletion of HA synthesis does not modify the expression profile
of keratinocyte differentiation markers
On the basis of the preceding observations, HA may have a
role in keratinocyte differentiation. To test this, keratinocyte
monolayers were treated with either 4-methylumbelliferone
(4MU), a widespread inhibitor of HA synthesis, or Strepto-
myces hyaluronidase, which degrades HA into small frag-
ments. 4MU was previously shown to decrease rat keratino-
cyte proliferation at concentrations of 0.2–1.0 mM (Rilla et al.,
2004). Using concentration-response experiments, we show
that 0.5 mM 4MU is both effective (475% decrease in HA
release) and relatively non-toxic (o25% cell mortality, if
treatment is started at C2 days) in cultured human keratino-
cytes (Supplementary Figure S4a and b online). Hyaluronidase
treatment removes all HA (Supplementary Figure S4c online).
However, exposure of cultures to either 0.5 mM 4MU or
1 U ml1 Streptomyces hyaluronidase during 48 hours did
not modify the expression profile of KRT10, IVL, or filaggrin
over the course of keratinocyte differentiation (Figure 2).
We conclude that HA synthesis is not involved in the
differentiation process of human keratinocytes.
Production of HA during the reconstruction of human epidermis
also correlates with HAS1 expression
The RHE with its air–liquid interface is a more physiological
model of the epidermis that can be studied without influence
of the dermis (Frankart et al., 2012). The amount of HA
released in the RHE medium increases progressively during
reconstruction (Figure 3a). The HA amount in the tissue is
about 100-fold the amount measured in the medium and
increases in a similar way during reconstruction (Figure 3b).
After 11 days, there is twice as much HA as there are proteins
(2mg HA per mg of total cell protein). Fluorescent detection of
HA in RHE sections shows a faint labeling after 1, 3, and 5
days and a dramatic increase after 7, 9, and 11 days of growth
as the tissue stratifies and accumulates KRT10 and IVL
suprabasally (Figure 3c). HA labeling surrounds all keratino-
cytes throughout the epithelium. This pattern mimics the
location of HA in normal epidermis in vivo (see Figure 5).
The mRNA expression levels of HASs and hyaluronidases
were also measured in RHE using quantitative PCR. HAS2 is
scarcely expressed in RHE, becoming detectable after 40
cycles of PCR only (data not shown). The level of HAS1
mRNA expression is stable over the duration of the culture
(Figure 4). In contrast, HAS3 expression progressively
decreases from the third day on, as soon as RHE expresses
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Figure 3. Hyaluronan (HA) concentration and distribution during the reconstruction of human epidermis. Reconstructed human epidermises (RHEs) were
obtained after 1, 3, 5, 7, 9, and 11 days of growth. The newly synthesized HA in the medium (a) and in the RHE layer (b) was measured every 48 hours and
normalized with respect to total cellular protein concentration. Data are shown as means±SEM (n¼ 3, analysis of variance one-repetition maximum, *Po0.05,
**Po0.01, ***Po0.001 vs. day 1). (c) RHEs obtained after 1, 3, 5, 7, 9, and 11 days of growth on polycarbonate filter at the air–liquid interface were fixed,
processed for histology, and stained for morphology (hematoxylin/eosin) or for HA (green) and nuclei (Hoechst 33258; blue). The differentiation process was
assessed based on the staining of keratin 10 (KRT10) and involucrin (IVL). Bar¼ 50mm.
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differentiation markers. A similar expression pattern is
observed for HYAL1 and HYAL2 (Supplementary Figure S2c
and d online).
The size of HA released by RHE at various time points was
analyzed using chromatography, revealing a broad profile of
molecular sizes (Supplementary Figure S1b online) similar
to that of the monolayers (Supplementary Figure S1a online).
This profile does not change significantly during RHE
differentiation.
Detectable HA is strongly increased in lesional epidermis of AD
patients and correlates with downregulation of HAS1 and
upregulation of HAS3
Previous studies have shown a link between HA and inflam-
matory skin diseases (Jameson et al., 2005; Ohtani et al.,
2009; Barnes et al., 2012). HA distribution and HAS
expression levels were investigated in biopsies of AD
patients and compared with in vitro data. Skin biopsy
specimens from an acute lesion and from surrounding
normal-appearing (non-lesional) skin of AD patients as well
as specimens from healthy volunteers were collected after
informed consent. As expected, morphologies of the non-
lesional and healthy skins (Figure 5a and b) appear identical.
HA staining in the normal epidermis is finely localized around
the cells of the basal and spinous layers (Figure 5d and e). AD
lesional skin sections, on the other hand, display distinctive
epidermal hyperplasia and parakeratosis (Figure 5c); (Oyoshi
et al., 2009). Yet, HA staining is as intense as in normal skin
sections and is localized in all intercellular spaces of lesional
epidermis (Figure 5f).
The dermis was partially visible on the sections. As often
demonstrated previously (Wells et al., 1991), it is filled with
compact HA staining (Figure 5d and e) except in AD lesions
where dermal HA staining is strikingly reduced (Figure 5f).
The mRNA expression level of HAS was measured using
quantitative PCR in similar 2-mm deep punch biopsies of 11
healthy skins, 9 non-lesional skins, and 9 lesional skins of AD
patients. The mean expression of HAS1 mRNA in the whole
skin (mostly epidermis) is decreased by 50% in both non-
lesional and lesional skin of AD patients compared with
healthy skin (Figure 5g). On the other hand, the relative
expression level of HAS3 mRNA is similar in healthy and non-
lesional skin but increases approximately 10-fold in AD
lesions. The relative expression level of HAS2 mRNA does
not differ significantly between samples. In view of their stable
expression in skin models (see Supplementary Figure S2
online), hyaluronidases were not evaluated in the biopsies.
Upregulation of HB-EGF can drive differential HAS expression in
AD skin
Several studies have shown that growth factors influence HAS
expression in keratinocytes (Sayo et al., 2002; Karvinen et al.,
2003; Pasonen-Seppanen et al., 2003) and we have just
shown that the HAS1/HAS3 ratio increases 100-fold in
response to anti-EGFR treatment (see Supplementary Figure
S3c online). Immunohistochemical HB-EGF labeling of the
biopsy specimens in the current study shows very little
signal in healthy skin but a strong marking in both lesional
and non-lesional AD epidermis (Figure 6). This is in line with
the results obtained in our previous study (Mathay et al.,
2011). To determine whether HB-EGF can induce differential
HAS expression in the epidermis, we measured the mRNA
levels of HAS1, HAS2, and HAS3 in RHE treated for 10 days
with recombinant human HB-EGF at concentrations ranging
from 0 to 25 ng ml 1. HAS2 mRNA is scarcely expressed
even after HB-EGF exposure (data not shown), but
HAS3 mRNA expression is dose-dependently elevated upon
incubation with HB-EGF (Figure 6g). Conversely, HAS1
expression decreases at high concentrations of the EGFR ligand
(Figure 6g).
Our data thus confirm that epidermal HB-EGF is induced
in AD patients and that it can modulate the expression of
HAS1 and HAS3 in the RHE model with the same pattern as in
AD itself.
DISCUSSION
This study was undertaken to assess the regulation of HA
production by HASs during spontaneous differentiation of
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Figure 4. mRNA expression of hyaluronan synthases (HASs) during the
reconstruction of human epidermis. Total RNA from reconstructed human
epidermis (RHE) obtained after 1, 3, 5, 7, 9, and 11 days of growth was
extracted, reverse transcription was performed, and cDNA was analyzed by
real-time PCR. The expression levels of HAS1–3, keratin 10 (KRT10), and
Loricrin (Lor) were normalized to the average expression of two housekeeping
genes (RPLP0 and TBP). The mRNA level at day 1 was taken as reference and
arbitrarily set at 1. The y axis is a logarithmic scale and error bars represent
95% confidence intervals (n¼ 3, analysis of variance one-repetition maximum,
*Po0.05, **Po0.01, ***Po0.001 vs. day 1).
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human epidermal keratinocytes in two models (monolayer
cultures and RHE) and in AD skin. The models contain no
dermis, making epidermal analysis easier but preventing
potential paracrine effects from the dermis. For instance,
EGF signaling is able to influence HA metabolism in
fibroblasts (Rock et al., 2012) and keratinocyte growth factor
may regulate HA metabolism of keratinocytes (Karvinen et al.,
2003).
In both culture models, HA was found to accumulate
with keratinocyte differentiation in parallel with an increase
in HAS1 mRNA expression and a decrease in HAS3.
The expression of HAS2 mRNA was very low both in vitro
and in vivo, and decreased further during differentiation
of the monolayer, suggesting that HAS2 has a minor role in
keratinocyte physiology. Similarly, we could not show
any role for hyaluronidases as HYAL1 and HYAL2 expre-
ssions were stable in monolayers and decreased during
epidermal reconstruction. Furthermore, both the monolayers
and RHE contained mostly high-molecular weight (4106 Da)
HA even in non-differentiating conditions when HAS1 was
weakly expressed. Human epidermal HA is also composed
of high-molecular weight (4106 Da) HA species (Tammi
et al., 1991).
At first sight, our results may seem discordant with existing
knowledge as published data indicate that HAS3 is responsible
for HA synthesis in keratinocytes, while HAS1 produces HA in
fibroblasts (Sayo et al., 2002; Yamada et al., 2004). However,
we believe that the results obtained in the current study based
on spontaneous differentiation of human keratinocytes
induced by cell density are very relevant for skin physiology.
In fact, the role of HAS3 in epidermal HA production was
previously demonstrated by incubating keratinocytes with
cytokines like transforming growth factor-b or IFN-g (Sayo
et al., 2002), growth factors like EGF or keratinocyte growth
factor (Pienimaki et al., 2001; Karvinen et al., 2003; Pasonen-
Seppanen et al., 2003), or RA (Saavalainen et al., 2005;
Pasonen-Seppanen et al., 2008). All these factors can interfere
with the balance of HASs. In our study, we also tested RA
and EGFR blockade on keratinocyte monolayers. Anti-EGFR
antibodies increased the HAS1/HAS3 expression ratio 100-
fold and RA decreased that ratio 100-fold. RA also increased
HAS2 expression, thus completely reversing the changes in
HAS1, HAS2, and HAS3 expression observed under
spontaneous differentiation. Interestingly, RA was also found
to increase HB-EGF expression (Giltaire et al., 2009),
suggesting that HB-EGF could explain the increase in HAS3
expression as observed in other models (Monslow et al.,
2009). In addition, treatment of RHE with HB-EGF decre-
ased the HAS1/HAS3 ratio 50-fold. All these observations
allow us to postulate that HAS1 and HAS3 are distinctly
regulated in keratinocytes, possibly by the EGFR pathway, and
likely function under different circumstances: HAS1 is the
most important HA-synthesizing enzyme during epidermal
differentiation, whereas the role of HAS3 emerges during
pathological conditions.
An important result of the current study is the fact that HA,
though produced at high levels during differentiation, is not
necessary for this process. Indeed, the expression profile of
differentiation markers was not modified when HA was
depleted using either 4MU or hyaluronidase treatment. More-
over, the HA is deposited mainly in keratinocyte layers in RHE
which are IVL negative and KRT10 low at later time points.
This might also indicate an independent regulation of kerati-
nocyte differentiation and HA synthesis.
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Figure 5. Hyaluronan (HA) distribution and mRNA expression of hyaluronan synthases (HASs) in atopic dermatitis (AD) skin samples. Sections of normal
skin (a, d), non-lesional skin of AD patient (b, e), and lesional skin of AD patient (c, f) were stained with hematoxylin/eosin/Saffron (a, b, c) or labeled with a
biotinylated HA-binding protein (d, e, f). Bar¼ 100mm. (g) Total RNA was extracted from biopsies of 11 normal skins, nine non-lesional skins of AD patients, and
nine lesional skins of AD patients. Real-time PCR was performed and the values are expressed relative to the means of 10 healthy samples. Statistical analyses
were performed by a paired Wilcoxon signed-rank test for the comparison of lesional versus non-lesional AD skin and by a Mann–Whitney test for the
comparisons of lesional and non-lesional versus healthy skin (*Po0.05, ***Po0.001).
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Correspondingly, the double-knockout mice that lack HAS1
and HAS3 do not present a disruption of epidermal differ-
entiation (Mack et al., 2011), although HAS2 could exert a
compensatory effect in that case. Our results thus clarify the
discrepancy in the literature about the link between HA and
keratinocyte differentiation. Some publications report that HA
induces differentiation (Bourguignon et al., 2006; Farwick
et al., 2011), whereas others demonstrate that HA inhibits
differentiation (Maytin et al., 2004; Passi et al., 2004). Our
study suggests HA is not involved in the process of
spontaneous epidermal differentiation.
However, HA could become critical in pathological condi-
tions. In particular, AD lesional skin showed a striking
upregulation of HAS3 and downregulation of HAS1 with no
significant changes in the amount or pattern of HA in the
epidermis. We can only speculate on the consequences of an
inverted HAS1/HAS3 ratio in AD lesions. There is no hint that
this switch could induce changes in the HA molecular size
profile, at least based on the measurements of HA molecular
weights during spontaneous keratinocyte differentiation.
However, recent experiments have shown that HAS3, but
not HAS1, can induce HA receptor-independent pericellular
coats and shedding of microvesicles (Rilla et al., 2013b;
Siiskonen et al., 2014). HAS3 can also function with a
lower concentration of intracellular UDP-linked substrates
than HAS1 (Rilla et al., 2013a). Any of these elements could
be involved in the switch to inflammation-activated
keratinocytes.
Our study also highlights the role of EGF ligands in
keratinocyte pathophysiology. In particular, HB-EGF was
overexpressed in AD skin and the HAS expression pattern in
RHE incubated with HB-EGF was identical to the pattern
observed in AD lesion, suggesting that HB-EGF could be a
critical factor able to modulate HAS expression in AD skin.
However, the strong labeling of HB-EGF in non-lesional
epidermis of AD patients indicates that HB-EGF likely needs
synergy with other molecules such as inflammatory cytokines
to regulate HAS expression pattern in AD lesions.
In conclusion, our study indicates that the balance of HA
produced by distinct HAS enzymes is critical for regulating
keratinocyte physiology. We have shown that HAS1 is
involved in the production of HA by keratinocytes
during normal differentiation, although suppression of HA
does not prevent this process. In contrast, HAS3 is likely
expressed by keratinocytes in response to stressing or in
pathological conditions such as AD while HAS1 is
downregulated. HB-EGF may have a role in HAS3 induction.
Future studies are required to elucidate the detailed mechan-
isms governing the balance between HAS1 and HAS3 epi-
dermal expression during differentiation and in pathological
conditions.
MATERIALS AND METHODS
Skin biopsies
See Supplementary Material online.
Cell culture and reconstruction of the epidermis
See Supplementary Material online.
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Figure 6. Heparin-binding EGF-like growth factor (HB-EBF) distribution in
atopic dermatitis (AD) skin and mRNA expression of hyaluronan synthases
(HASs) during reconstruction of human epidermis incubated with HB-EGF.
Sections of normal skin (a, d), non-lesional skin of AD patient (b, e), and lesional
skin of AD patient (c, f) were labeled (a, b, c) or not (d, e, f) with an antibody
against HB-EBF (d, e, f). Bar¼50mm. (g) Reconstructed human epidermises
(RHEs) were incubated at first day of reconstruction with concentrations of
recombinant heparin-binding EGF-like growth factor (rHB-EGF) ranging from 0 to
25 ng ml1. rHB-EGF was renewed every 2 days until 11th day of reconstruction.
Total RNA was extracted from each culture and real-time PCR was performed.
The mRNA levels of 0 ng ml1 rHB-EGF were arbitrarily set at 1 and error bars
represent 95% confidence intervals (n¼3, analysis of variance one-repetition
maximum, *Po0.05 vs. 0 ng ml1 condition).
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Measurements of HA concentrations
The cell medium was collected to measure extracellular HA;
then cells were treated with trypsin to collect pericellular HA;
finally they were lysed with 0.1 M Tris-HCl buffer (pH 7.4)
containing 10 mM CaCl2 to measure intracellular or intra-tissular
HA. The medium and extracts were incubated overnight with 500
mU ml 1 Pronase (Sigma-Aldrich, Bornem, Belgium) at 55 1C. HA
concentration was quantified using Hyaluronan DuoSet kit (R&D
systems, Abingdon, UK). Total cell protein concentration was mea-
sured using Pierce Protein Assay (ThermoScientific, Rockford, IL).
Total RNA isolation and quantitative PCR
Total RNA was extracted from monolayers using High Pure RNA
isolation kit (Roche, Basel, Switzerland) and from RHE using RNeasy
kit (Qiagen, Hilden, Germany). cDNA was generated from 1mg of
total RNA using the Super Script II reverse transcriptase kit (Invitrogen,
Merelbeke, Belgium). cDNA was amplified using FastStart Universal
SYBR Green Master (Roche, Basel, Switzerland) in a 7300 real-time
PCR machine (Applied Biosystems, Lennik, Belgium). Primers (Sigma-
Aldrich) were used at 300 nM. They are listed in Supplementary Table
S1 online. mRNA levels were normalized to geometric mean of
RPL13A and TBP mRNA expression levels (Minner and Poumay,
2009). Data were analyzed using the DDCT quantitative method
(Livak and Schmittgen, 2001).
Labeling
RHE or biopsies were fixed in 4% formalin in 70% ethanol–5% glacial
acetic acid to improve HA detection (Lin et al., 1997), embedded
in paraffin, and sectioned with a microtome. Tissue sections were
deparaffinized, rehydrated, and rinsed in water. Sections were blocked
and permeabilized for 1 hour in phosphate-buffered saline (PBS)
containing 0.2% BSA (PAA Laboratories GmbH, Pasching, Austria)
and 0.02% Triton X-100 (Merck, Darmstadt, Germany). For HA
labeling, slides were incubated overnight at 4 1C with biotinylated
HA-binding complex (generously given by Professor Markku Tammi)
diluted 1:50 in the above solution. After washing, all slices were
incubated for 1 hour in fluorescein streptavidin (Vector Laboratories,
Burlingame, CA). Nuclei were counterstained with Hoechst 33258
(Molecular Probes, Eugene, OR). Slices were mounted using Mowiol
(Sigma-Aldrich, Steinheim, Germany) for observation on an Olympus
AX70 microscope. Immunolabeling of HB-EGF (Mathay et al., 2008),
IVL, and KRT10 (Frankart et al., 2012) was performed as described.
Statistical analysis
HA concentration and mRNA expression data were analyzed
using one-way analysis of variance and Holm–Sidak test on
results of three independent experiments in each model. Statistical
analyses of biopsy mRNA expression levels were performed using
either paired Wilcoxon signed-rank test or Mann–Whitney test
(Bonferroni corrected).
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